|
Statement
| 1.Date of occurrence of the change:2022/05/27
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):Institutional director,
independent director, natural-person director
3.Title and name of the previous position holder:
Independent Directors: Chien-Huang Lin, Chih-Li Wang, Sonny Wang
Directors: Ming-Feng Hou
Directors:
Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu, Wen-Hwa Chang,
Rui-Wen Wu
Legal Representative of National Development Fund, Executive Yuan:
Chi-Ying Huang, Yi-Hui Lin
4.Resume of the previous position holder:
Wen-Hwa Chang: Vice Chairman, TTY Biopharm Co., Ltd
Sonny Wang: Ex-Secretary, Taiwan Corporate Governance Association
Chi-Ying Huang: Chairman, Institute of Biopharmaceutical Sciences National
Yang-Ming University
Chien-Huang Lin: President, Taipei Medical University
Ming-Feng Hou: Professor, Surgery-Kaohsiung Medical University Chung-Ho
Memorial Hospital
Chih-Li Wang: Accountant, Moores Rowland CPAs
Ted Tu: Chairman, PharmaEngine, Inc
Rui-Wen Wu: Special Assistant of Chairman, TTY Biopharm Co., Ltd
Yi-Hui Lin: Director, Audit Affairs at National Development Fund,
Executive Yuan.
5.Title and name of the new position holder:
Independent Directors: Chien-Huang Lin, Ming-Daw Chang, Chih-Li Wang
Directors: Ming-Feng Hou
Directors:
Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu, Wen-Hung Hsu,
Rui-Wen Wu
Legal Representative of National Development Fund, Executive Yuan:
Ming-Shiang Wu, Yi-Hui Lin
6.Resume of the new position holder:
Chien-Huang Lin: President, Taipei Medical University
Ming-Daw Chang: Chairman, Bank of Panhsin
Chih-Li Wang: Accountant, Moores Rowland CPAs
Ming-Feng Hou: Professor, Surgery-Kaohsiung Medical University Chung-Ho
Memorial Hospital
Ted Tu: Chairman, PharmaEngine, Inc
Wen-Hung Hsu: Senior Vice President & Co-founder , WT MICROELECTRONICS
Rui-Wen Wu: Special Assistant of Chairman, TTY Biopharm Co., Ltd
Ming-Shiang Wu: Superintendent, National Taiwan University Hospital
Yi-Hui Lin: Director, Audit Affairs at National Development Fund,
Executive Yuan.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):tenure expired
8.Reason for the change:tenure expired
9.Number of shares held by the new position holder when elected:
(1) Independent Director: Chien-Huang Lin: 0 shares
(2) Independent Director: Ming-Daw Chang: 0 shares
(3) Independent Director: Chih-Li Wang: 3,021 shares
(4) Director: Ming-Feng Hou: 0 shares
(5) Director: TTY Biopharm Co., Ltd. : 25,866,808 shares
(6) Director: National Development Fund, Executive Yuan: 22,585,654 shares
(7) Director: Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu:
30,000 shares
10.Original term (from __________ to __________):108/06/13~111/06/12
11.Effective date of the new appointment:2022/05/27
12.Turnover rate of directors of the same term:N/A
13.Turnover rate of independent directors of the same term:N/A
14.Turnover rate of supervisors of the same term:N/A
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:None
|
